Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neurofibromatosis 1 2Neoplasms 2Smoking Cessation 1Smoking 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Fatigue 1Cognition Disorders 1Carcinoma, Hepatocellular 1Cancer Pain 1Breast Neoplasms 1Bone Neoplasms 1Anxiety Disorders 1Anti-N-Methyl-D-Aspartate Receptor Encephalitis 1Agnosia 1Abdominal Pain 1

Interventions

Morphine 11Oxycodone 8Fentanyl 6nabiximols 5Methadone 4Hydromorphone 4Acetaminophen 3Transcutaneous Electric Nerve Stimulation 2Tapentadol 2Naloxone 2Lidocaine 2Buprenorphine 2Acupuncture Therapy 2tanezumab 1resiniferatoxin 1oxycodone naloxone combination 1fulranumab 1cannabichromene 1alvimopan 1Water 1Ultracet 1Transcranial Direct Current Stimulation 1Tramadol 1Therapeutic Touch 1Telemedicine 1Tablets 1Surveys and Questionnaires 1Sugars 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cancer Pain × Transcranial Direct Current Stimulation × Clear all
NCT02366611 2021-01-22

Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck Cancer

University of Michigan

Phase NA Completed
11 enrolled 9 charts
Head & Neck

Cancer Pain, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡